BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patle R, Shinde S, Patel S, Maheshwari R, Jariyal H, Srivastava A, Chauhan N, Globisch C, Jain A, Tekade RK, Shard A. Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing. Bioorg Med Chem Lett 2021;42:128062. [PMID: 33901643 DOI: 10.1016/j.bmcl.2021.128062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Proniewicz E, Gralec B, Ozaki Y. Homogeneous Pt nanostructures surface functionalized with phenylboronic acid phosphonic acid derivatives as potential biochemical nanosensors and drugs: SERS and TERS studies. J Biomed Mater Res B Appl Biomater 2023. [PMID: 36715221 DOI: 10.1002/jbm.b.35225] [Reference Citation Analysis]
2 Jaiswal E, Globisch C, Jain A. Knowledge-driven design and optimization of potent symmetric anticancer molecules: A case study on PKM2 activators. Comput Biol Med 2022;151:106313. [PMID: 36450217 DOI: 10.1016/j.compbiomed.2022.106313] [Reference Citation Analysis]
3 Rihan M, Vineela Nalla L, Dharavath A, Patel S, Shard A, Khairnar A. Boronic acid derivative activates pyruvate kinase M2 indispensable for redox metabolism in oral cancer cells. Bioorg Med Chem Lett 2022;:128539. [PMID: 35007726 DOI: 10.1016/j.bmcl.2022.128539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Arora S, Joshi G, Chaturvedi A, Heuser M, Patil S, Kumar R. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2. J Med Chem 2021. [PMID: 34726055 DOI: 10.1021/acs.jmedchem.1c00981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]